229 results on '"Martinowitz, Uri"'
Search Results
2. Four Decades of Carrier Detection and Prenatal Diagnosis in Hemophilia A: Historical Overview, State of the Art and Future Directions
3. Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial
4. Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment
5. Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry
6. Surfactant impairs coagulation in-vitro: A risk factor for pulmonary hemorrhage?
7. Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B
8. Correction of Hemophilia as a Proof of Concept for Treatment of Monogenic Diseases by Fetal Spleen Transplantation
9. Hypertension, haematuria and renal functioning in haemophilia – a cross-sectional study in Europe
10. Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: an interventional dilemma: case series, review of the literature, and tips for management
11. Continuous Infusion of Coagulation Products in Hemophilia
12. Phacoemulsification of Cataract in Patients Receiving Coumadin Therapy: Ocular and Hematologic Risk Assessment
13. Updates in the management of severe coagulopathy in trauma patients
14. Continuous Infusion of Coagulation Products in Hemophilia
15. The molecular genetics of haemophilia A: screening for point mutations in the factor VIII gene using the restriction enzyme TaqI
16. Intravenous rFVIIa Administered for Hemorrhage Control in Hypothermic Coagulopathic Swine with Grade V Liver Injuries
17. Intermittent injections vs. continuous infusion of Factor VIII in haemophilia patients undergoing major surgery
18. Anaerobic power and muscle strength in young hemophilia patients
19. Treatment of traumatic bleeding with recombinant factor VIIa
20. The Use of Fibrin Tissue Adhesive to Reduce Blood Loss and the Need for Blood Transfusion After Total Knee Arthroplasty: A Prospective, Randomized, Multicenter Study*
21. Dental extractions in patients maintained on continued oral anticoagulant: Comparison of local hemostatic modalities
22. Extensive Venous and Arterial Thrombosis Associated With an Inhibitor to Activated Protein C
23. Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial
24. The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency
25. Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients: A randomised, active-controlled, double-blind study
26. Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program
27. Ilio-psoas hematoma—its detection, and treatment with special reference to hemophilia
28. Pseudotumors in Patients with Hemophilia
29. Continuous Infusion of Coagulation Products in Hemophilia
30. Pseudotumors in Patients with Hemophilia
31. Efficacy, PK and Safety Results of Clinical Study Of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) In Previously Treated Patients With Hemophilia B
32. Trace FVIII Augments Rfviia Induced Thrombin Generation and Improves Hemostasis in Hemophilia A Patients with Inhibitors: A clinical Cohort Study
33. Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: an interventional dilemma: case series, review of the literature, and tips for management
34. Recombinant Porcine Factor VIII Corrects Thrombin Generation and Improves Clot Structure In Vitro in Plasma Containing Anti-Factor VIII Inhibitory Antibodies
35. Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis
36. Differential Roles of Fibrinogen and von Willebrand Factor on Clot Formation and Platelet Adhesion in Reconstituted and Immune Thrombocytopenia
37. A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor
38. Pseudotumors in Patients with Hemophilia
39. Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial
40. Enhancement of Pig Embryonic Implants in Factor VIII KO Mice: A Novel Role for the Coagulation Cascade in Organ Size Control
41. A Rapidly Progressive, Life-Threatening Postpartum Hemorrhage
42. Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors
43. Continuous infusion of coagulation factors: current opinion
44. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII
45. Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine
46. New Concepts in Managing Catastrophic Bleeding: A Combat Perspective
47. Evaluation of Stability of a Sucrose-Formulated, Full-Length rFVIII for Use in Continuous Infusion Therapy.
48. The treatment of haemophilic intraosseous bone cyst of the talus
49. Early Use of Recombinant Factor VIIa Improves Mean Arterial Pressure and May Potentially Decrease Mortality in Experimental Hemorrhagic Shock: A Pilot Study
50. The Management of Catastrophic Bleeds in Trauma and Surgery by an Injury Site Specific Agent (Recombinant Activated Factor VII)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.